BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11092546)

  • 21. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class.
    Popieniek PH; Pratt RF
    Anal Biochem; 1987 Aug; 165(1):108-13. PubMed ID: 3688425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum.
    Ferain T; Hobbs JN; Richardson J; Bernard N; Garmyn D; Hols P; Allen NE; Delcour J
    J Bacteriol; 1996 Sep; 178(18):5431-7. PubMed ID: 8808932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of vancomycin.
    Schäfer M; Schneider TR; Sheldrick GM
    Structure; 1996 Dec; 4(12):1509-15. PubMed ID: 8994975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Configurational entropy and cooperativity between ligand binding and dimerization in glycopeptide antibiotics.
    Jusuf S; Loll PJ; Axelsen PH
    J Am Chem Soc; 2003 Apr; 125(13):3988-94. PubMed ID: 12656635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics.
    LeTourneau DL; Allen NE
    Anal Biochem; 1997 Mar; 246(1):62-6. PubMed ID: 9056183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance.
    Kim SJ; Cegelski L; Preobrazhenskaya M; Schaefer J
    Biochemistry; 2006 Apr; 45(16):5235-50. PubMed ID: 16618112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
    Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
    Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotational-echo double resonance characterization of vancomycin binding sites in Staphylococcus aureus.
    Kim SJ; Cegelski L; Studelska DR; O'Connor RD; Mehta AK; Schaefer J
    Biochemistry; 2002 Jun; 41(22):6967-77. PubMed ID: 12033929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulated dipeptide recognition by vancomycin.
    Li D; Sreenivasan U; Juranic N; Macura S; Puga FJ; Frohnert PM; Axelsen PH
    J Mol Recognit; 1997; 10(2):73-87. PubMed ID: 9376130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding studies of vancomycin to the cytoplasmic peptidoglycan precursors by affinity capillary electrophoresis.
    Liu J; Volk KJ; Lee MS; Pucci M; Handwerger S
    Anal Chem; 1994 Jul; 66(14):2412-6. PubMed ID: 8080114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
    Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
    Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
    Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Carboxyl Terminus of Eremomycin Facilitates Binding to the Non-d-Ala-d-Ala Segment of the Peptidoglycan Pentapeptide Stem.
    Chang J; Zhou H; Preobrazhenskaya M; Tao P; Kim SJ
    Biochemistry; 2016 Jun; 55(24):3383-91. PubMed ID: 27243469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bio-inspired synthetic receptor molecules towards mimicry of vancomycin.
    Monnee MC; Brouwer AJ; Verbeek LM; van Wageningen AM; Liskamp RM
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1521-5. PubMed ID: 11412973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.
    Leung SS; Tirado-Rives J; Jorgensen WL
    Bioorg Med Chem; 2009 Aug; 17(16):5874-86. PubMed ID: 19620008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics.
    Billot-Klein D; Gutmann L; Bryant D; Bell D; Van Heijenoort J; Grewal J; Shlaes DM
    J Bacteriol; 1996 Aug; 178(15):4696-703. PubMed ID: 8755902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E; Frasch HJ; Kilian R; Pozzi R
    Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
    Xing B; Jiang T; Wu X; Liew R; Zhou J; Zhang D; Yeow EK
    Chemistry; 2011 Dec; 17(50):14170-7. PubMed ID: 22083883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.